Oct 28, 4:09 PM ET
Pitney Bowes reported third-quarter 2026 revenue of $456 million, down 1% from $460 million a year earlier, while adjusted EPS rose 35% to $0.42 and GAAP diluted EPS rose 23% to $0.37. The company raised the low end of its full-year revenue guidance and its adjusted free cash flow range, and narrowed its adjusted EBIT and adjusted EPS ranges while keeping their midpoints.
- Q3 2026 revenue $456 million vs. $460 million in Q3 2025; GAAP diluted EPS $0.37 vs. $0.30; adjusted EPS $0.42 vs. $0.31
- 2026 revenue guidance low end raised to $1.83 billion from $1.80 billion; high end unchanged at $1.86 billion
- 2026 adjusted free cash flow guidance raised to $380 million to $420 million from $360 million to $410 million
- Debt reduced by $148 million in the quarter; quarterly dividend of $0.10 per share payable December 8, 2026
Read the filing on SEC.gov ↗
Sep 30, 8:08 AM ET
Pitney Bowes and its subsidiaries amended their credit agreement on September 29, 2026, reducing the interest rate margin on $585.5 million of tranche B term loans by 75 basis points. The company expects the change to cut annual interest expense by about $4 million, and the March 2032 maturity and other terms are unchanged.
- Tranche B term loans outstanding of $585.5 million; margin cut from 375 to 300 basis points over Term SOFR, or 3.00%, and 2.00% for Base Rate loans
- Company expects annual interest expense to fall by about $4 million based on the current principal balance
- Maturity date (March 2032) and other loan terms unchanged, per the press release
- S&P Global Ratings upgraded the issuer credit rating to 'BB-' from 'B+'
Read the filing on SEC.gov ↗
Jul 29, 4:09 PM ET
Pitney Bowes reported second-quarter 2026 revenue of $451 million, down 2% from $462 million a year earlier, while GAAP diluted EPS rose to $0.36 from $0.17 and adjusted EPS rose to $0.43 from $0.27. The company raised its 2026 guidance for Adjusted EBIT, Adjusted EPS and Adjusted Free Cash Flow and reaffirmed its revenue guidance, and its Board formed a Strategic Review Committee to explore options including a sale of the company.
- Q2 2026 revenue was $451 million, down from $462 million; GAAP net income was $50 million versus $30 million
- 2026 Adjusted EBIT guidance raised to $445 million-$475 million from $425 million-$465 million; Adjusted EPS guidance raised to $1.55-$1.70 from $1.50-$1.65
- Presort Services revenue fell 5% and Adjusted Segment EBIT fell 44%; SendTech Solutions Adjusted Segment EBIT rose 21%
- Board approved a $0.10 quarterly dividend payable September 8, 2026; the company reduced debt by $201 million since the end of Q1 2026
Read the filing on SEC.gov ↗
Jul 27, 8:05 AM ET
Pitney Bowes appointed La Vonda Williams, former CFO of Onegevity Health, to its Board of Directors effective July 21, 2026. She joins the Audit, Governance and Strategic Review Committees, and the filing describes the Strategic Review Committee as formed in connection with the company's previously announced strategic review process.
- Appointed to the Board on July 21, 2026, with a $200,000 annual cash retainer plus committee fees under the standard non-management director arrangements
- Committee roles: Audit Committee and Governance Committee (additional $20,000 and $12,000 annual cash retainers), and Strategic Review Committee (extra equity grant of $278,000, prorated to $225,446)
- Also receives an annual equity grant of $100,000, prorated to $81,095 for her mid-year start, that vests one year later
- Filing states no arrangements or understandings tied to her appointment and no related-party transactions under Item 404(a)
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
